Профілактика побічної дії цитостатичної терапії у порожнині рота у хворих на рак молочної залози та її ефективність
Сергій Миколайович Григоров, І.С. Сухіна, А.М. Насонова · Experimental and Clinical Dentistry · 2018
This study is devoted to one of the most severe complications of the breast cancer patients treatment - oral mucositis, which leads to the interruption of the treatment, makes a bad influence on the disease prognosis, decrease of the treatment efficacy and quality of life of cancer patients. Heilitis is the most frequent side-effect, which has a highest manifestation rate during the III cycle of chemotherapy - 69.2 ± 9.2% with a subsequent gradual decrease up to 34.6 ± 9.5% at the VI cycle. The appearence of hyposalivation is observed with the maximal rate at II cycle of chemotherapy - 61,5 ± 9,7%, with a subsequent decrease of its manifestations up to 26,9 ± 8,9% at cycle VI. The mucositis-rate increases by the III cycle of chemotherapy up to 73.1 ± 8.9%, with the subsequent decrease of it up to 34.6 ± 9.5% at the VI cycle of chemotherapy. The paraodontal tissues disease was observed more often during the II-IV cycle of chemotherapy - 26,9 ± 8,9%, with a subsequent decrease up to 7,7 ± 5,3% at the VI cycle of chemotherapy. The authors have developed a complex of the preventive and therapeutic care for these patients, which application contributed to the possible decrease of the side-effects in the oral cavity in comparison to the other group in 1.5 times during the I cycle of chemotherapy (56.9 ± 5.9%) and in 4,5 times at the 6th cycle of chemotherapy (18,1 ± 4,6%). The heilitis-rate was decreased in 5,2 times and paraodontal tissues disease-rate in 13,4 times at I cycle of chemotherapy versus the comparison group, in which there were almost no side-effects at the VI cycle of chemotherapy (1, 4 and 0%, respectively); mucositis-rate was in 2.4 times lower at the I cycle of chemotherapy, up to 8.2 times at the VI cycle of chemotherapy; the hyposalivation was probably in 1,7 times lower, than at the I cycle of chemotherapy, and up to 2,5 times at the V cycle of chemotherapy versus the comparison group. The authors constitute, the preventive and therapeutic oral care should be prescribed for each cancer patient during the chemotherapy. Keywords: breast cancer, chemotherapy, oral cavity, cheilitis, mucositis, salivary gland dysfunction, therapeutic and preventive measures.
Cited by 0 works.